181 related articles for article (PubMed ID: 17601378)
21. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
Coppo R; Peruzzi L; Amore A; Piccoli A; Cochat P; Stone R; Kirschstein M; Linné T
J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
[TBL] [Abstract][Full Text] [Related]
22. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
[TBL] [Abstract][Full Text] [Related]
23. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
[TBL] [Abstract][Full Text] [Related]
25. Proteinuria: clinical signficance and basis for therapy.
Woo KT; Lau YK
Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
[TBL] [Abstract][Full Text] [Related]
26. Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy.
Asano T; Tatsuma N; Yoshida J; Ohashi R; Ambo K; Tsuchiya M; Murakami M; Yamanaka N; Honda M; Yamamoto M
Clin Nephrol; 1999 Jun; 51(6):335-40. PubMed ID: 10404693
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
[TBL] [Abstract][Full Text] [Related]
28. [I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis].
Kaliev RR; Budaĭchiev AB; Aldashev AA; Mirrakhimov MM
Ter Arkh; 2005; 77(6):12-5. PubMed ID: 16078593
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children.
Gheissari A; Salehi M; Dastjerdi SB; Jahangiri M; Hooman N; Otookesh H; Merikhipour A; Ajir A; Foroughmand A; Khatami S; Shahidi S; Atapour A; Seirafian S; Naeini AE
Nephrology (Carlton); 2008 Dec; 13(8):708-11. PubMed ID: 19076285
[TBL] [Abstract][Full Text] [Related]
30. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.
Szelestei T; Bähring S; Kovács T; Vas T; Salamon C; Busjahn A; Luft FC; Nagy J
Am J Kidney Dis; 2000 Sep; 36(3):468-73. PubMed ID: 10977777
[TBL] [Abstract][Full Text] [Related]
31. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
Savin M; Petronić V
Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
[TBL] [Abstract][Full Text] [Related]
32. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation.
Kanno Y; Okada H; Yamaji Y; Nakazato Y; Suzuki H
QJM; 2005 Mar; 98(3):199-203. PubMed ID: 15728401
[TBL] [Abstract][Full Text] [Related]
34. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
35. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
36. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies.
Shehab DK; Al-Jarallah KF; Al-Awadhi AM; Al-Herz A; Nahar I; Haider MZ
J Biomed Sci; 2008 Jan; 15(1):61-7. PubMed ID: 17713861
[TBL] [Abstract][Full Text] [Related]
37. [Some metabolic and genetic risk factors and the progression of IgA nephropathy--preliminary report].
Sulikowska B; Czarny J; Rość D; Odrowaz-Sypniewska G; Manitius J; Sliwka DM
Pol Merkur Lekarski; 2006 Aug; 21(122):132-5; discussion 136. PubMed ID: 17144095
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men.
Frimat L; Philippe C; Maghakian MN; Jonveaux P; DE Ligny BH; Guillemin F; Kessler M
J Am Soc Nephrol; 2000 Nov; 11(11):2062-2067. PubMed ID: 11053482
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
40. ACE gene polymorphism in peripheral vascular disease.
Başar Y; Salmayenli N; Aksoy M; Seçkin S; Aydin M; Ozkök E
Horm Metab Res; 2007 Jul; 39(7):534-7. PubMed ID: 17611909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
